Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Metformin in Combination with Vincristine, Irinotecan, and Temozolomide
Show Display Options
Rank Status Study
1 Recruiting Metformin in Children With Relapsed or Refractory Solid Tumors
Conditions: Solid Tumors;   Primary Brain Tumors
Interventions: Drug: Vincristine sulfate;   Drug: Irinotecan;   Drug: Temozolomide;   Drug: Metformin

Indicates status has not been verified in more than two years